Skip to main content
Log in

Leucine amino peptidase a better indicator of disseminated malignant disease

  • Published:
Indian Journal of Clinical Biochemistry Aims and scope Submit manuscript

Abstract

Leucine amino peptidase (LAP) activity was studied in serum and urine samples of 25 healthy ambulant subjects, 20 patients with localised and 41 patients with malignant disseminated disease. Serum levels of the enzyme were elevated but not significantly in both localised and disseminated disease whereas the urinary activity of the enzyme was markedly elevated in disseminated disease (p<0.001) as compared to localised disease. This quantitative method used for determination is reliable, accurate, simple, rapid and cost effective and therefore has better application as an indicator of disseminated disease in a clincal setting.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Arst, H.E., Manning, R.T. and Delp, M. (1959) Serum leucine amino peptidase activity: findings in carcinoma of the pancreas, pregnancy and other disorders. Am. J. Med. Sc. 238, 598–609.

    Article  CAS  Google Scholar 

  2. Bressler, R., Forsyth, B.R. and Klatskin, G. (1960) Serum leucine amino peptidase activity in hepatobiliary and pancreatic disease. J. Lab. & Clin. Med. 56, 417–430.

    CAS  Google Scholar 

  3. Derrick, J.B., Heagy, F.C., Urtasun, R. and Swartz, D.P. (1963) A comparison of the leucine amino peptidase with the hepatoscan in the investigation of suspected liver metastasis. Clin. Chem. 9, 448–449.

    Google Scholar 

  4. Sathe, S.B. and Taskar, S.P. (1982) Leucine amino peptidase levels in hepatic and certain gastrointestinal tract cancers. JAPI. 30, 83.

    PubMed  CAS  Google Scholar 

  5. Ghadge, M.S., Sirsat, A.V., Bhansali, M.S., Desouza, L.J. and Jagannath, P. (2001) Leucine amino peptidase a better indicator of carcinoma of liver, biliary tract and pancreas. Ind. J. Clin. Biochem. 16, 60–64.

    Article  CAS  Google Scholar 

  6. Szasz, G. (1964) Serum leucine amino peptidase activity in acute lesions of the liver parenchyma. Lancet, i, 441–442.

    Article  Google Scholar 

  7. Khanolkar, M.M., Sirsat, A.V., Deshmane, V.H. and Kamat, M.R. (1992) Serum leucine amino peptidase levels as markers in testicular tumors. Ind. J. Med. Res. 96, 372–375.

    CAS  Google Scholar 

  8. Szasz, G. (1967) A kinetic photometric method for serum leucine amino peptidase. Am. J. Clin. Path. 47, 607–613.

    PubMed  CAS  Google Scholar 

  9. Larsen, K. (1972). Creatinine assay by a reaction kinetic principle. Clin. Chim. Acta 41, 209.

    Article  PubMed  CAS  Google Scholar 

  10. Phillips, R.W. and Manildi, E.R. (1970) Elevation of leucine amino peptidase in disseminated malignant disease. Cancer, 26, 1006–1012.

    Article  PubMed  CAS  Google Scholar 

  11. Rutenburg, A.M., Goldberg, J.A. and Pineda, E.P. (1958) Leucine aminopeptidase activity Observations in patients with cancer of pancreas and other diseases. New Engl. J. Med. 259, 469–472.

    PubMed  CAS  Google Scholar 

  12. Hoffman, E., Nachlas, M.M., Gaby, S.D., Abrams, S.J. and Seligman, A.M. (1960) Limitations in the diagnostic value of serum leucine aminopeptidase. New Engl. J. Med. 263, 541–544.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ghadge, M.S., Raste Leucine amino peptidase a better indicator of disseminated malignant disease. Indian J Clin Biochem 19, 149–151 (2004). https://doi.org/10.1007/BF02894275

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02894275

Keywords

Navigation